SARS-CoV-2 (COVID-19) by NAA
Also known as: COVID19NAA
Use
This test is used to detect the presence of the 2019 novel coronavirus, SARS-CoV-2, in individuals who meet clinical and/or epidemiological criteria for SARS-CoV-2. It is used to confirm infection by identifying the SARS-CoV-2 RNA in a patient's sample, aiding in the diagnosis and management of COVID-19. A 'Detected' result indicates the presence of viral RNA, supporting the diagnosis of acute COVID-19 infection. It is essential for clinical correlation with patient history and other diagnostic information.
Special Instructions
Not provided.
Limitations
Not Detected results do not rule out the presence of PCR inhibitors or virus nucleic acid concentration below the detection level. Detected results could be false positives and require clinical correlation to determine infection status. Reliable results depend on proper specimen collection, transport, storage, and handling. Saliva and undiluted saliva are unacceptable specimens.
New York Approved
Methodology
PCR-based (NAAT)
Biomarkers
SARS-CoV-2
Microorganism
LOINC Codes
- 31208-2 - Specimen source
- 94500-6 - SARS-CoV-2 RNA Resp Ql NAA+probe
Result Turnaround Time
1-4 days
Related Documents
For more information, please review the documents below
Specimen
Nasopharyngeal Swab
Volume
Not provided
Minimum Volume
Not provided
Container
Viral transport media (ARUP supply #12884)
Collection Instructions
Place swab in viral transport media and seal in an individual bag.
Storage Instructions
Frozen
Causes for Rejection
Saliva, undiluted saliva, swabs not in media, wood swabs, calcium alginate swabs, specimens in glass tubes.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 2 days |
| Refrigerated | 3 days |
| Frozen | 30 days |
Other tests from different labs that may be relevant